4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-23-003750
CFO and Chief Business Officer acquired 33,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO and Chief Business Officer | 2023-01-17 | Grant or award | +33,500 | 109,687 | D | ||
| Derivatives | |||||||
| Zuga Matt CFO and Chief Business Officer | 2023-01-17 | Grant or award · Employee Stock Option (right to buy) | +150,800 | 150,800 | D | ||
Loading xslF345X03/doc4.xml…